Previous close | 4.0100 |
Open | 3.9800 |
Bid | 4.0000 x 1100 |
Ask | 4.3500 x 1100 |
Day's range | 3.8800 - 4.3150 |
52-week range | 3.1300 - 7.6900 |
Volume | |
Avg. volume | 157,167 |
Market cap | 109.663M |
Beta (5Y monthly) | 1.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.9100 |
Earnings date | 14 Aug 2023 - 18 Aug 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 9.80 |
It's not a stretch to say that DarioHealth Corp.'s ( NASDAQ:DRIO ) price-to-sales (or "P/S") ratio of 3.4x right now...
At this time, I would like to welcome everyone to the Amwell Q1 2023 earnings call. This is Sue Dooley of Amwell investor relations and joining me today are Amwell's chairman and CEO, Dr. Ido Schoenberg; and Bob Shepardson, our CFO.
There's been a notable change in appetite for DarioHealth Corp. ( NASDAQ:DRIO ) shares in the week since its yearly...
A look at the shareholders of DarioHealth Corp. ( NASDAQ:DRIO ) can tell us which group is most powerful. And the group...
DarioHealth Corp. ( NASDAQ:DRIO ) shareholders should be happy to see the share price up 13% in the last month. But...
Today is shaping up negative for DarioHealth Corp. ( NASDAQ:DRIO ) shareholders, with the analysts delivering a...
Every investor in DarioHealth Corp. ( NASDAQ:DRIO ) should be aware of the most powerful shareholder groups. Insiders...